inositol phosphoceramide

Term ID

CHEBI:60245

Synonyms

ceramide phosphoinositols
inositol phosphorylceramide
inositolphosphoceramide

Definition

A phosphosphingolipid in which an inositol residue and the ceramide moiety are linked via a phosphodiester bridge. The ceramide moiety contains substituents R(1) and R(2) which vary with different sphingoid bases and fatty acyl moieties.

References

PMID:9804825

Ontology

ChEBI ( EBI )

Relationships

is a type of: phosphosphingolipid

phosphosphingolipid Show first 5 Terms
has subtype: alpha-D-glucuronosyl-(1<->6)-1D-myo-inositol-1-phospho-N-[(R)-2-hydroxy-very-long-chain fatty acyl]-(R)-4-hydroxysphingoid base(2-) inositol phosphodihydroceramide inositol phosphophytoceramide inositol phosphosphingolipid Ins-1-P-Cer B/B' ... Show All 32 Terms

alpha-D-glucuronosyl-(1<->6)-1D-myo-inositol-1-phospho-N-[(R)-2-hydroxy-very-long-chain fatty acyl]-(R)-4-hydroxysphingoid base(2-) inositol phosphodihydroceramide inositol phosphophytoceramide inositol phosphosphingolipid Ins-1-P-Cer B/B' Ins-1-P-Cer(d18:0/2-OH-24:0) Ins-1-P-Cer(d18:0/2-OH-26:0) Ins-1-P-Cer(d18:0/24:0) Ins-1-P-Cer(d18:0/26:0) Ins-1-P-Cer(d20:0/2-OH-24:0) Ins-1-P-Cer(d20:0/2-OH-26:0) Ins-1-P-Cer(d20:0/24:0) Ins-1-P-Cer(d20:0/26:0) Ins-1-P-Cer(t18:0/2,3-OH-24:0) Ins-1-P-Cer(t18:0/2,3-OH-26:0) Ins-1-P-Cer(t18:0/2-OH-24:0) Ins-1-P-Cer(t18:0/2-OH-26:0) Ins-1-P-Cer(t18:0/24:0) Ins-1-P-Cer(t18:0/26:0) Ins-1-P-Cer(t20:0/2,3-OH-24:0) Ins-1-P-Cer(t20:0/2,3-OH-26:0) Ins-1-P-Cer(t20:0/2-OH-24:0) Ins-1-P-Cer(t20:0/2-OH-26:0) Ins-1-P-Cer(t20:0/24:0) Ins-1-P-Cer(t20:0/26:0) Ins-1-P-Cer-A Ins-1-P-Cer-C Ins-1-P-Cer-D mannosyl diphosphorylinositol ceramide mannosylinositol phosphorylceramide N-(2-hydroxyhexacosanoyl)phytosphingosine-1-phospho-(1D-myo-inositol) PI-Cer(t38:0) Show first 5 Terms
inverse is_conjugate_base_of: inositol phosphoceramide(1-)

inositol phosphoceramide(1-) Show first 5 Terms
is_conjugate_acid_of: inositol phosphoceramide(1-)

inositol phosphoceramide(1-) Show first 5 Terms

Phenotype

Phenotype resulting from inositol phosphoceramide

Phenotype where environments contain inositol phosphoceramide

Phenotype modified by environments containing inositol phosphoceramide

Human Disease Model